NEWARK, Del., Aug. 4, 2011 /PRNewswire/ — Lightwave Logic,
Inc. (OTC Bulletin Board:
LWLG), a technology company focused on the development of a
Next Generation Non Linear Optical Polymer Materials
Platform for applications in high speed fiber-optic data
communications and optical computing, announced today that it has
entered into an agreement with FiberLogix International Ltd. of
Watford, UK to begin the development and testing of proprietary
fiber optic medical diagnostic devices incorporating Lightwave
Logic’s advanced non-linear optical polymers.
FiberLogix’s primary focus is to design all-fiber solutions
incorporating their expertise in fiber manufacturing and side
polish technologies. Shafiq Parwaz, Director of Technical
Applications for FiberLogix, said, “Our Company has pioneered a new
technique to process fiber in such a way as to make a waveguide in
the sidewall. The basic platform has been successfully
demonstrated for the sensing and measurement of Hydrogen but the
exploitation of our technology combined with Lightwave Logic’s
polymers has the potential to innovate and mass produce biomedical
sensors and create other applications like sensors for infectious
agents. These are extremely large markets addressing many billions
of dollars of revenue opportunity. Importantly, this can be
accomplished at extremely low cost.”
Jim Marcelli, CEO of Lightwave Logic, commented, “We are very
pleased to work with FiberLogix. We believe that the
combination of their unique manufacturing skills and our polymer
expertise will give birth to a host of high value devices and
technologies that can address many different end markets.
This represents a significant potential revenue opportunity
for our company in a completely new market for us and further
demonstrates the utility of our advanced organic polymer technology
platform.”
‘/>”/>
SOURCE